Search

Author/Creator Guidoboni, Massimo

11. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Issue 2 (10th January 2022)

Authors:
Wolchok, Jedd D.; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C. Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O.; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John ...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 2(2022)
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis. (February 2021)

Authors:
Monti, Manlio; Guidoboni, Massimo; Oboldi, Devil; Bartolini, Giulia; Pieri, Federica; Ruscelli, Silvia; Passardi, Alessandro; Ridolfi, Laura; De Rosa, Francesco; Sullo, Francesco Giulio; Frassineti, Giovanni Luca
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Issue 2 (1st September 2022)

Authors:
Ascierto, Paolo A.; Mandalà, Mario; Ferrucci, Pier Francesso; Guidoboni, Massimo; Rutkowski, Piotr; Ferraresi, Virginia; Arance, Ana; Guida, Michele; Maiello, Evaristo; Gogas, Helen; Richtig, Erika; Fierro, Maria Teresa; Lebbè, Celeste; Helgadottir, Hildur; Queirolo, Paola; Spagnolo, Francesco; T...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis. (3rd May 2011)

Authors:
Ridolfi, Laura; Petrini, Massimiliano; Fiammenghi, Laura; Granato, Anna Maria; Ancarani, Valentina; Pancisi, Elena; Scarpi, Emanuela; Guidoboni, Massimo; Migliori, Giuseppe; Sanna, Stefano; Tauceri, Francesca; Verdecchia, Giorgio Maria; Riccobon, Angela; Ridolfi, Ruggero
Other Names:
Fleischer Bernhard Academic Editor.
Journal:
Clinical & developmental immunology
Issue:
Volume 2010(2010)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis. (5th September 2010)

Authors:
Ridolfi, Laura; Petrini, Massimiliano; Fiammenghi, Laura; Granato, Anna Maria; Ancarani, Valentina; Pancisi, Elena; Scarpi, Emanuela; Guidoboni, Massimo; Migliori, Giuseppe; Sanna, Stefano; Tauceri, Francesca; Verdecchia, Giorgio Maria; Riccobon, Angela; Ridolfi, Ruggero
Other Names:
Fleischer Bernhard Academic Editor.
Journal:
Clinical & developmental immunology
Issue:
Volume 2010(2010)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis. (5th September 2010)

Authors:
Ridolfi, Laura; Petrini, Massimiliano; Fiammenghi, Laura; Granato, Anna Maria; Ancarani, Valentina; Pancisi, Elena; Scarpi, Emanuela; Guidoboni, Massimo; Migliori, Giuseppe; Sanna, Stefano; Tauceri, Francesca; Verdecchia, Giorgio Maria; Riccobon, Angela; Ridolfi, Ruggero
Other Names:
Fleischer Bernhard Academic Editor.
Journal:
Clinical & developmental immunology
Issue:
Volume 2010(2010)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗